• Babraham Hall CambridgeAberystwyth Innovation and Enterprise Campus Aberystwyth
  • Call us on +44 (0) 1223 804075

PHOTO:  From Left: Prof Conrad Lichtenstein (Nemesis CSO), Dr Frank Massam (Nemesis CEO), Dr Takeshi Shiota (Shionogi SVP, Pharmaceutical Research Division) and Dr Kai Stoeber (Shionogi VP, Global Innovation). Japanese Pharma Company Joins £1.4M Seed Funding Round for Nemesis Bioscience Nemesis Bioscience today announced the completion of a Seed funding round of £1.4M from a syndicate of

Nemesis Bioscience Ltd (Cambridge, UK) announced today that it has been awarded an Entrepreneurship Award by King’s College, Cambridge. The King’s College judges, who include current members of the College as well as alumni Gerard Mizrahi, Hermann Hauser and Stuart Lyons, reached their decision after detailed presentations on the company’s business plan, technology and intellectual